セボフルラン吸入麻酔薬のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Inhalation Sevoflurane Anaesthetic Agent Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16437 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

セボフルラン吸入麻酔薬市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のセボフルラン吸入麻酔薬の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のセボフルラン吸入麻酔薬の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 セボフルラン吸入麻酔薬市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・ジェネリック医薬品、ブランド医薬品 用途別セグメントは次のように区分されます。 ・子供用、大人用 世界のセボフルラン吸入麻酔薬市場の主要な市場プレーヤーは以下のとおりです。 ・AbbVie、Baxter、Maruishi Pharmaceutical、Jiangsu Hengrui、Lunan Pharmaceutical 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、セボフルラン吸入麻酔薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なセボフルラン吸入麻酔薬メーカーの企業概要、2019年～2021年までのセボフルラン吸入麻酔薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なセボフルラン吸入麻酔薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別セボフルラン吸入麻酔薬の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのセボフルラン吸入麻酔薬の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのセボフルラン吸入麻酔薬市場予測を収録しています。 ・第12、13、14章では、セボフルラン吸入麻酔薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：AbbVie、Baxter、Maruishi Pharmaceutical、Jiangsu Hengrui、Lunan Pharmaceutical ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ジェネリック医薬品、ブランド医薬品 ・用途別分析2016年-2026年：子供用、大人用 ・セボフルラン吸入麻酔薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・セボフルラン吸入麻酔薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・セボフルラン吸入麻酔薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・セボフルラン吸入麻酔薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・セボフルラン吸入麻酔薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Inhalation Sevoflurane Anaesthetic Agent market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Inhalation Sevoflurane Anaesthetic Agent size is estimated to be million in 2021 from USD million in 2020, with a change of % between 2020 and 2021. The global Inhalation Sevoflurane Anaesthetic Agent market size is expected to grow at a CAGR of % for the next five years.

Market segmentation
Inhalation Sevoflurane Anaesthetic Agent market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Generic Drug
Brand Drug

Market segment by Application can be divided into
Chidren
Adult

The key market players for global Inhalation Sevoflurane Anaesthetic Agent market are listed below:
AbbVie
Baxter
Maruishi Pharmaceutical
Jiangsu Hengrui
Lunan Pharmaceutical

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Inhalation Sevoflurane Anaesthetic Agent product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Inhalation Sevoflurane Anaesthetic Agent, with price, sales, revenue and global market share of Inhalation Sevoflurane Anaesthetic Agent from 2019 to 2021.
Chapter 3, the Inhalation Sevoflurane Anaesthetic Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Inhalation Sevoflurane Anaesthetic Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Inhalation Sevoflurane Anaesthetic Agent market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Inhalation Sevoflurane Anaesthetic Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Inhalation Sevoflurane Anaesthetic Agent Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Generic Drug
1.2.3 Brand Drug
1.3 Market Analysis by Application
1.3.1 Overview: Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Chidren
1.3.3 Adult
1.4 Global Inhalation Sevoflurane Anaesthetic Agent Market Size & Forecast
1.4.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Value (2016-2026))
1.4.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume (2016-2026)
1.4.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2026) & (US$/Unit)
1.5 Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity Analysis
1.5.1 Global Inhalation Sevoflurane Anaesthetic Agent Total Production Capacity (2016-2026)
1.5.2 Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Inhalation Sevoflurane Anaesthetic Agent Market Drivers
1.6.2 Inhalation Sevoflurane Anaesthetic Agent Market Restraints
1.6.3 Inhalation Sevoflurane Anaesthetic Agent Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product and Services
2.1.4 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Product and Services
2.2.4 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Maruishi Pharmaceutical
2.3.1 Maruishi Pharmaceutical Details
2.3.2 Maruishi Pharmaceutical Major Business
2.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product and Services
2.3.4 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Jiangsu Hengrui
2.4.1 Jiangsu Hengrui Details
2.4.2 Jiangsu Hengrui Major Business
2.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product and Services
2.4.4 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Lunan Pharmaceutical
2.5.1 Lunan Pharmaceutical Details
2.5.2 Lunan Pharmaceutical Major Business
2.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product and Services
2.5.4 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturer
3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Inhalation Sevoflurane Anaesthetic Agent
3.4 Market Concentration Rate
3.4.1 Top 3 Inhalation Sevoflurane Anaesthetic Agent Manufacturer Market Share
3.4.2 Top 6 Inhalation Sevoflurane Anaesthetic Agent Manufacturer Market Share
3.5 Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Inhalation Sevoflurane Anaesthetic Agent Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Region (2016-2026)
4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2026)
4.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026)
4.3 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026)
4.4 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026)
4.5 South America Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026)
4.6 Middle East and Africa Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Type (2016-2026)
5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2026)
5.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Application (2016-2026)
6.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2026)
6.3 Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2026)
7.2 North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2026)
7.3 North America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
7.3.1 North America Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Country (2016-2026)
7.3.2 North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2026)
8.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2026)
8.3 Europe Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
8.3.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Country (2016-2026)
8.3.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2026)
9.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2026)
9.3 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Market Size by Region
9.3.1 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2026)
10.2 South America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2026)
10.3 South America Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
10.3.1 South America Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Country (2016-2026)
10.3.2 South America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2026)
11.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2026)
11.3 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Market Size by Country
11.3.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Inhalation Sevoflurane Anaesthetic Agent Typical Distributors
12.3 Inhalation Sevoflurane Anaesthetic Agent Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type, (USD Million), 2021-2026
Table 2. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Major Business
Table 5. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product and Services
Table 6. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Baxter Basic Information, Manufacturing Base and Competitors
Table 8. Baxter Major Business
Table 9. Baxter Inhalation Sevoflurane Anaesthetic Agent Product and Services
Table 10. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Maruishi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 12. Maruishi Pharmaceutical Major Business
Table 13. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product and Services
Table 14. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Jiangsu Hengrui Basic Information, Manufacturing Base and Competitors
Table 16. Jiangsu Hengrui Major Business
Table 17. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product and Services
Table 18. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Lunan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Lunan Pharmaceutical Major Business
Table 21. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product and Services
Table 22. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Inhalation Sevoflurane Anaesthetic Agent, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Inhalation Sevoflurane Anaesthetic Agent Production Site of Key Manufacturer
Table 28. Inhalation Sevoflurane Anaesthetic Agent New Entrant and Capacity Expansion Plans
Table 29. Inhalation Sevoflurane Anaesthetic Agent Mergers & Acquisitions in the Past Five Years
Table 30. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021e) & (K Units)
Table 31. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units)
Table 32. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021e) & (USD Million)
Table 33. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026) & (USD Million)
Table 34. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 35. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 36. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021e) & (USD Million)
Table 37. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2021-2026) & (USD Million)
Table 38. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2021e) & (US$/Unit)
Table 39. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2021-2026) & (US$/Unit)
Table 40. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 41. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 42. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2016-2021e) & (USD Million)
Table 43. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Application (2021-2026) & (USD Million)
Table 44. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2016-2021e) & (US$/Unit)
Table 45. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2021-2026) & (US$/Unit)
Table 46. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021e) & (K Units)
Table 47. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units)
Table 48. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021e) & (USD Million)
Table 49. North America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2021-2026) & (USD Million)
Table 50. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 51. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 52. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 53. North America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 54. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021e) & (K Units)
Table 55. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units)
Table 56. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021e) & (USD Million)
Table 57. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2021-2026) & (USD Million)
Table 58. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 59. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 60. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 61. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 62. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021e) & (K Units)
Table 63. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021-2026) & (K Units)
Table 64. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021e) & (USD Million)
Table 65. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2021-2026) & (USD Million)
Table 66. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 67. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 68. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 69. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 70. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021e) & (K Units)
Table 71. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units)
Table 72. South America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021e) & (USD Million)
Table 73. South America Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2021-2026) & (USD Million)
Table 74. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 75. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 76. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 77. South America Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 78. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021e) & (K Units)
Table 79. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2021-2026) & (K Units)
Table 80. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021e) & (USD Million)
Table 81. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2021-2026) & (USD Million)
Table 82. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021e) & (K Units)
Table 83. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2021-2026) & (K Units)
Table 84. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021e) & (K Units)
Table 85. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2021-2026) & (K Units)
Table 86. Direct Channel Pros & Cons
Table 87. Indirect Channel Pros & Cons
Table 88. Inhalation Sevoflurane Anaesthetic Agent Typical Distributors
Table 89. Inhalation Sevoflurane Anaesthetic Agent Typical Customers
List of Figures
Figure 1. Inhalation Sevoflurane Anaesthetic Agent Picture
Figure 2. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020
Figure 3. Generic Drug
Figure 4. Brand Drug
Figure 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2020
Figure 6. Chidren
Figure 7. Adult
Figure 8. Global Inhalation Sevoflurane Anaesthetic Agent Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Inhalation Sevoflurane Anaesthetic Agent Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. Global Inhalation Sevoflurane Anaesthetic Agent Sales (2016-2026) & (K Units)
Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2026) & (US$/Unit)
Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity (2016-2026) & (K Units)
Figure 13. Global Inhalation Sevoflurane Anaesthetic Agent Production Capacity by Geographic Region: 2020 VS 2021
Figure 14. Inhalation Sevoflurane Anaesthetic Agent Market Drivers
Figure 15. Inhalation Sevoflurane Anaesthetic Agent Market Restraints
Figure 16. Inhalation Sevoflurane Anaesthetic Agent Market Trends
Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Manufacturer in 2020
Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Manufacturer in 2020
Figure 19. Inhalation Sevoflurane Anaesthetic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. Top 3 Inhalation Sevoflurane Anaesthetic Agent Manufacturer (Revenue) Market Share in 2020
Figure 21. Top 6 Inhalation Sevoflurane Anaesthetic Agent Manufacturer (Revenue) Market Share in 2020
Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2026)
Figure 23. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2016-2026)
Figure 24. North America Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026) & (USD Million)
Figure 25. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026) & (USD Million)
Figure 26. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026) & (USD Million)
Figure 27. South America Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026) & (USD Million)
Figure 28. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue (2016-2026) & (USD Million)
Figure 29. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2026)
Figure 30. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2026)
Figure 31. Global Inhalation Sevoflurane Anaesthetic Agent Price by Type (2016-2026) & (US$/Unit)
Figure 32. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 33. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2026)
Figure 34. Global Inhalation Sevoflurane Anaesthetic Agent Price by Application (2016-2026) & (US$/Unit)
Figure 35. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2026)
Figure 36. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 37. North America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2026)
Figure 38. North America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2026)
Figure 39. United States Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2026)
Figure 43. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 44. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2026)
Figure 45. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2026)
Figure 46. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2026)
Figure 52. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2016-2026)
Figure 55. China Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Korea Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2026)
Figure 62. South America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 63. South America Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2026)
Figure 64. South America Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2026)
Figure 68. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Egypt Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Saudi Arabia Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. South Africa Inhalation Sevoflurane Anaesthetic Agent Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source

---